Sun F, Yu Z. Rapid progression of condyloma acuminatum caused by IL-17A antibody treatment: a case report.
Front Med (Lausanne) 2024;
11:1387620. [PMID:
38813385 PMCID:
PMC11133628 DOI:
10.3389/fmed.2024.1387620]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2024] [Accepted: 04/30/2024] [Indexed: 05/31/2024] Open
Abstract
Anti interleukin (IL)-17A therapy is a common and effective treatment for psoriasis, but there are also risks of infection. In this case, we presented a patient who experienced a swift progression of condyloma acuminatum on the genitals during psoriasis treatment with secukinumab, a human IL-17A antagonist. Through this case, we strongly suspect that anti IL-17A treatment may promote the onset and rapid progression of low-risk HPV-associated condyloma acuminatum.
Collapse